MILLENIUM BIOLOGIX INC has a total of 51 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, materials and metallurgy and biotechnology are XPAND BIOTECHNOLOGY B V, EPIBONE INC and AVITA MEDICAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 10 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Australia | 4 | |
#6 | Brazil | 4 | |
#7 | China | 3 | |
#8 | Japan | 3 | |
#9 | New Zealand | 3 | |
#10 | Finland | 1 | |
#11 | United Kingdom | 1 | |
#12 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Materials and metallurgy | |
#3 | Biotechnology | |
#4 | Pharmaceuticals | |
#5 | Surface technology and coating | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Building materials | |
#3 | Implantable devices | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Treatment of glass | |
#7 | Coating metallic material | |
#8 | Microbiology | |
#9 | Therapeutic chemical compounds | |
#10 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Smith Timothy J N | 37 |
#2 | Pugh Sydney M | 35 |
#3 | Sayer Michael | 18 |
#4 | Langstaff Sarah Dorthea | 14 |
#5 | Davies John E | 8 |
#6 | Tommasini Roberto | 6 |
#7 | Larcher Yves | 6 |
#8 | Sindrey Dennis R | 6 |
#9 | Pecaric Martin R | 5 |
#10 | Misener D Lowell | 5 |
Publication | Filing date | Title |
---|---|---|
CA2599823A1 | Reverse-flow perfusion of three-dimensional scaffolds | |
EP1504033A2 | Connective tissue stimulating peptides | |
WO03087292A2 | Automated tissue engineering system | |
US6846493B2 | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity | |
CA2312264A1 | A high temperature materials processing furnace | |
WO9938542A1 | A synthetic biomaterial compound | |
EP0847376A1 | An artificial stabilized composition of calcium phosphate phases particularly adapted for supporting bone cell activity | |
JPH0956369A | Multiwell bone cell culture device | |
JPH0956805A | Improved sintering method for thin film manufacturing of calcium phosphate material | |
GB9500791D0 | Protein crystal growth system | |
EP0666902A1 | Assessment of bone cell activity |